CHIMÄRE POLYNUKLEOTIDE

Patent europeic · EP3169693 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3169693
Numer da la dumonda
EP15822890
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
16-07-2015
Publitgà
24-05-2017
Concedì
09-03-2022
Stritgà
23-02-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07H 21/02 (2006.01)
Prioritad
US 201462025399 P 16.07.2014
US 201462045359 P 03.09.2014
Dumonda PCT
PCT/US2015/040699 16.07.2015
Publicaziun PCT
WO2016/011226 21.01.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-02-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.02.2023

  2. 18-01-2023

    Midada

    Published in Swissreg on 18.01.2023

  3. 09-03-2022

    Concedì

    Published in Swissreg on 09.03.2022

Partidas

Possessur

ModernaTx, Inc.

ModernaTX, Inc.

200 Technology Square, Cambridge, MA 02139, US

Inventur

NELSON, Jennifer Ann

Brookline, MA 02446, US

RHODEN SMITH, Amy

Somerville, Massachusetts 02143, US

FRALEY, Andrew

Arlington, Massachusetts 02474, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.